Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 8
- 0 vs. Q3 2021
- Portfolio value
- $329.1M
- −$44.2M (−11.8%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CPNGCoupang, Inc. | CL A | 3,164,571 | $93.0M | 28.3% | −1,100,000−25.8% | Reduced | History |
| RCUSArcus Biosciences, Inc. | COM | 1,612,077 | $65.2M | 19.8% | −230,000−12.5% | Reduced | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,819,690 | $60.8M | 18.5% | −45,920−0.6% | Reduced | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $50.6M | 15.4% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $26.3M | 8.0% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,000,000 | $16.7M | 5.1% | +1,000,000 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $14.8M | 4.5% | 00.0% | Unchanged | History |
| UBXUnity Biotechnology, Inc. | COM | 1,094,998 | $1.60M | 0.5% | 00.0% | Unchanged | History |
Sold out since Q3 2021 (1)
Positions held at the end of Q3 2021 that are gone from this filing.